Home Cart 0 Sign in  
X

[ CAS No. 619-45-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 619-45-4
Chemical Structure| 619-45-4
Chemical Structure| 619-45-4
Structure of 619-45-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 619-45-4 ]

Related Doc. of [ 619-45-4 ]

Alternatived Products of [ 619-45-4 ]

Product Details of [ 619-45-4 ]

CAS No. :619-45-4 MDL No. :MFCD00007891
Formula : C8H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :LZXXNPOYQCLXRS-UHFFFAOYSA-N
M.W : 151.16 Pubchem ID :12082
Synonyms :

Calculated chemistry of [ 619-45-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.13
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 1.35
Log Po/w (WLOGP) : 1.06
Log Po/w (MLOGP) : 1.32
Log Po/w (SILICOS-IT) : 0.97
Consensus Log Po/w : 1.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.9
Solubility : 1.91 mg/ml ; 0.0126 mol/l
Class : Very soluble
Log S (Ali) : -2.05
Solubility : 1.34 mg/ml ; 0.0089 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.1
Solubility : 1.21 mg/ml ; 0.008 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 619-45-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 619-45-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 619-45-4 ]
  • Downstream synthetic route of [ 619-45-4 ]

[ 619-45-4 ] Synthesis Path-Upstream   1~32

  • 1
  • [ 82698-67-7 ]
  • [ 2527-96-0 ]
  • [ 82698-69-9 ]
  • [ 619-45-4 ]
Reference: [1] Tetrahedron Letters, 1982, vol. 23, # 13, p. 1327 - 1330
  • 2
  • [ 619-45-4 ]
  • [ 22090-27-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 19, p. 8524 - 8537,14
  • 3
  • [ 619-45-4 ]
  • [ 582-80-9 ]
Reference: [1] Patent: WO2014/128465, 2014, A1,
  • 4
  • [ 129694-52-6 ]
  • [ 619-45-4 ]
  • [ 931424-12-3 ]
  • [ 1187-42-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2007, vol. 44, # 1, p. 13 - 19
  • 5
  • [ 100-37-8 ]
  • [ 619-45-4 ]
  • [ 59-46-1 ]
Reference: [1] Canadian Journal of Chemistry, 1990, vol. 68, # 6, p. 903 - 907
[2] Patent: DE172568, , ,
  • 6
  • [ 619-45-4 ]
  • [ 94-25-7 ]
Reference: [1] Journal of the American Chemical Society, 1921, vol. 43, p. 1323
  • 7
  • [ 619-45-4 ]
  • [ 29886-62-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 17, p. 2203 - 2214
  • 8
  • [ 19099-93-5 ]
  • [ 619-45-4 ]
  • [ 95798-23-5 ]
  • [ 1037834-44-8 ]
Reference: [1] Organic Syntheses, 2013, vol. 90, p. 74 - 86
[2] Organic Process Research and Development, 2012, vol. 16, # 2, p. 255 - 259
  • 9
  • [ 619-45-4 ]
  • [ 4123-72-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 11, p. 3210 - 3222
  • 10
  • [ 619-45-4 ]
  • [ 66493-39-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 22, p. 10299 - 10314
  • 11
  • [ 619-45-4 ]
  • [ 608-30-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 11, p. 3210 - 3222
  • 12
  • [ 619-45-4 ]
  • [ 7143-01-3 ]
  • [ 7151-76-0 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 44, p. 6300 - 6303
  • 13
  • [ 619-45-4 ]
  • [ 7151-76-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 9, p. 1873 - 1882
  • 14
  • [ 619-45-4 ]
  • [ 13402-32-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 11, p. 3210 - 3222
  • 15
  • [ 150-13-0 ]
  • [ 619-45-4 ]
  • [ 56961-25-2 ]
Reference: [1] Patent: EP279698, 1990, A3,
  • 16
  • [ 619-45-4 ]
  • [ 41727-48-4 ]
Reference: [1] Patent: US5502073, 1996, A,
[2] Patent: EP279698, 1990, A3,
  • 17
  • [ 619-45-4 ]
  • [ 19718-49-1 ]
YieldReaction ConditionsOperation in experiment
100% With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethaneHeating / reflux A solution of methyl 4-aminobenzoate (5.0 g; 0.033 mol.), benzyltrimethylammonium dichloroiodate (22.1 g; 0.056 mol.) and calcium carbonate (5.0 g; 0.050 mol.) in a mixture of dichloromethane (200 ml) and methanol (100 ml_) were stirred and heated under reflux overnight. The solution was cooled, washed with saturated sodium bisulphate, dried and evaporated to afford the desired product (9.6 g; quant.) which was used directly EPO <DP n="32"/>without further purification. 1 H NMR (400 MHz, DMSOd6) δ ppm 3.75 (s, 3 H) 6.09 (s, 2 H) 6.75 (d, J=8.59 Hz, 1 H) 7.66 (dd, J=8.59, 2.02 Hz, 1 H) 8.11 (d, J=2.02 Hz, 1 H).
100% With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethaneHeating / reflux A solution of methyl 4-aminobenzoate (5.0 g; 0.033 mol.), benzyltrimethylammonium dichloroiodate (22.1 g; 0.056 mol.) and calcium carbonate (5.0 g; 0.050 mol.) in a mixture of dichloromethane(200 ml) and methanol (100 ml.) were stirred and heated under reflux overnight. The solution was cooled, washed with saturated sodium bisulphate, dried and evaporated to afford the desired product (9.6 g; quant.) which was used directly without further purification. 1 H NMR (400 MHz, DMSOd6) δ ppm 3.75 (s, 3 H) 6.09 (s, 2 H) 6.75 (d, J=8.59 Hz, 1 H)7.66 (dd, J=8.59, 2.02 Hz, 1 H) 8.1 1 (d, J=2.02 Hz, 1 H).
93% With pyridine iodine monochloride In methanol for 2 h; Reflux; Inert atmosphere To a stirred solution of methyl 4-aminobenzoate 18 (1.0 g, 6.62 mmol, 1.0 eq.) in methanol (60 mL) was added pyridinium iodochloride (1.60 g, 6.62 mmol, 1.0 eq.). The reaction mixture was refluxed for 2h under nitrogen atmosphere. After cooling to room temperature, the mixture was concentrated in vacuo. The reaction was diluted with ethyl acetate and washed with brine. The organic layer was dried over MgSO4 and was concentrated in vacuo. The crude was purified by chromatography on silica gel column (cyclohexane/EtOAc, gradient 100:0 to 70:30) and concentrated under reduced pressure to afford the compound 19, as a pale yellow solid (93percent yield); mp 90°C; 1H NMR (CDCl3, 500 MHz) δ 8.33 (d, 4J = 1.9 Hz, 1H), 7.81 (dd, 3J = 8.5 Hz, 4J = 2.0 Hz, 1H), 6.70 (d, 3J = 8.5 Hz, 1H), 4.53 (br s, 2H), 3.85 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 166.0 (CO), 150.9 (Cq), 141.2 (CH), 131.4 (CH), 121.4 (CH), 113.3 (Cq), 82.3 (Cq), 52.0 (CH3); IR (neat, cm-1) ν 3472, 3365, 2997, 2948, 2844, 1684, 1627, 1249, 764. Spectral and analytical data matched with literature.[2]
90% With N-iodo-succinimide; [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) In dichloromethane; toluene at 20℃; for 14 h; General procedure: To a stirred solution of the substrate (1 mmol) in CH2Cl2 or (CH2Cl)2 (0.1 M) were added Ph3PAuNTf2 (0.025 mmol, 19 mg; complex Ph3PAuNTf2 toluene, 2:1) followed by N-iodosuccinimide (1.1 mmol, 248 mg). The resulting solution was stirred at r.t. or under reflux until complete conversion of the starting material. After removal of the solvent under reduced pressure, the crude material was purified by flash column chromatography using different gradients of hexanes and EtOAc to obtain the pure desired products.
73% With Iodine monochloride In acetic acid at 20 - 30℃; for 1 h; 10,4 g (68,8 [MMOL) 4-AMINOBENZOESaeUREMETHYLESTER] wurden in 100 ml Essigsaeure geloest und mit 11,17 g (68,8 [MMOL)] [LODMONOCHLORID] in 100 ml Essigsaeure versetzt. Dabei stieg die Reaktionstemperatur [AUF 30°C] an. Nach einer Stunde bei Raumtemperatur wurde auf [10percent] ige Natriumhydrogencarbonat-Loesung gegossen, mit Dichlormethan extrahiert, die organische Phase getrocknet und eingeengt. Man erhielt 14 g (73 percent) des gewuenschten Produktes.

Reference: [1] Patent: WO2007/38331, 2007, A2, . Location in patent: Page/Page column 30-31
[2] Patent: WO2007/103759, 2007, A2, . Location in patent: Page/Page column 48
[3] European Journal of Medicinal Chemistry, 2019, p. 234 - 248
[4] European Journal of Organic Chemistry, 2001, # 24, p. 4607 - 4613
[5] Synlett, 2014, vol. 25, # 3, p. 399 - 402
[6] Tetrahedron Letters, 2002, vol. 43, # 5, p. 787 - 790
[7] Advanced Synthesis and Catalysis, 2007, vol. 349, # 7, p. 1159 - 1172
[8] RSC Advances, 2014, vol. 4, # 36, p. 18930 - 18932
[9] Tetrahedron, 1990, vol. 46, # 13/14, p. 4587 - 4594
[10] Tetrahedron Letters, 1986, vol. 27, # 11, p. 1293 - 1296
[11] Journal of Organic Chemistry, 2003, vol. 68, # 5, p. 1843 - 1851
[12] Patent: WO2003/104188, 2003, A1, . Location in patent: Page 27, 28
[13] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2722 - 2725
[14] Tetrahedron Letters, 1997, vol. 38, # 14, p. 2439 - 2442
[15] Chemical Communications, 2017, vol. 53, # 24, p. 3481 - 3484
[16] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 3, p. 227 - 237
[17] Organic Letters, 2005, vol. 7, # 10, p. 2043 - 2046
[18] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 21, p. 5646 - 5649
[19] Journal of Organic Chemistry, 2002, vol. 67, # 18, p. 6395 - 6405
[20] Patent: WO2008/73865, 2008, A2, . Location in patent: Page/Page column 62
[21] Patent: US2002/19527, 2002, A1,
[22] Patent: WO2007/138033, 2007, A1, . Location in patent: Page/Page column 33-34
  • 18
  • [ 619-45-4 ]
  • [ 69812-51-7 ]
Reference: [1] ChemSusChem, 2017, vol. 10, # 1, p. 151 - 155
  • 19
  • [ 619-45-4 ]
  • [ 101184-08-1 ]
Reference: [1] Synthesis, 2003, # 17, p. 2661 - 2666
  • 20
  • [ 619-45-4 ]
  • [ 102121-60-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[2] Chemical and Pharmaceutical Bulletin, 1986, vol. 34, # 5, p. 2275 - 2278
  • 21
  • [ 619-45-4 ]
  • [ 1352622-18-4 ]
  • [ 128742-76-7 ]
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 1, p. 41 - 44
  • 22
  • [ 619-45-4 ]
  • [ 555-06-6 ]
Reference: [1] Chemische Berichte, 1986, vol. 119, # 5, p. 1627 - 1639
  • 23
  • [ 619-45-4 ]
  • [ 84228-44-4 ]
YieldReaction ConditionsOperation in experiment
83% With copper(II) choride dihydrate; lithium chloride hydrate In ethanol for 48 h; Reflux General procedure: A round-bottomed flask (25 mL) was charged with substrate (2 mmol), CuCl2·2H2O (6 mmol), LiCl·H2O (2 mmol) and EtOH (4 mL). The resulting reaction mixture was stirred at reflux. After the completion of the reaction monitored by TLC, EtOH was removed under reduced pressure. Then ammonium hydroxide (4 mL, 25percent) and water (10 mL) were added and the aqueous phase was extracted with ethyl acetate (10 mL×3). The combined organic phase was washed with brine (8 mL×3) and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure. The crude mixture was purified by chromatography on silica gel to obtain the desired products.
Reference: [1] Synlett, 1999, # 12, p. 1984 - 1986
[2] Synthesis, 1985, # 6/7, p. 669 - 670
[3] Synthetic Communications, 2018, vol. 48, # 20, p. 2708 - 2714
  • 24
  • [ 109-92-2 ]
  • [ 619-45-4 ]
  • [ 108166-01-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2011, vol. 50, # 33, p. 7670 - 7673
  • 25
  • [ 619-45-4 ]
  • [ 106896-49-5 ]
YieldReaction ConditionsOperation in experiment
93% With N-Bromosuccinimide In chloroform at 0℃; for 3 h; Preparation 166: 4-Amino-3-bromo-benzoic acid methyl ester; [1367] 4-Amino-benzoic acid methyl ester (17g, O.lmol) was dissolved in chloroform(25OmL). N-bromosuccinimide (2Og, O.lmol) was added at O0C, and at the same temperature the mixture was stirred for 3 h. The solvent was distilled off, and ethyl acetate (10OmL) was added to the residue. The mixture was washed with aqueous sodium chloride solution. The organic layer was separated, dried over anhydrous magnesium sulfate, filtered and purified from hexane to give the title compound (24.3g, Yield 93percent).[1368] NMR: 1H-NMR(CDCl3) δ 8.11(1H, d), 7.79-7.77(1H, m), 6.72(1H, d), 4.51(2H, br s), 3.85(3H, s)
1.4 g at 0℃; To a stirred solution of compound I (1.51 g) in acetic acid Br2 (1.59 g) was added at 0 °C. A large quantity of white solid was obtained. TCL result showed that no starting material remained. The solid was purified by column chromatography on silica gel (DCM:CH3OH = 20:1) to afford a white solid compound II (1.4g). The subsequent reaction followed the procedure outlined in Section 4.2.1.Total yield 0.7percent, brownish yellow, 1H NMR (400 MHz, DMSO-d6): δ 7.034 (s, 3H), 7.731 (dd, J1 = 11.4 Hz, J2 = 1.60 Hz, 1H), 7.955 (d, J = 1.60 Hz, 1H), 8.647 (d, J = 8.80 Hz, 1H), 9.556 (s, 1H); 13C NMR (100 MHz, DMSO-d6): δ 179.38, 178.73, 159.26, 138.54, 128.52, 124.86, 123.93, 121.62, 116.51; HRMS (ESI) found: 345.9439, [C9H8N5S2BrO + H]+ calcd: 345.9432.
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 21, p. 10410 - 10416
[2] Patent: WO2010/93191, 2010, A2, . Location in patent: Paragraph 1365-1368
[3] Organic Letters, 2015, vol. 17, # 12, p. 2886 - 2889
[4] European Journal of Medicinal Chemistry, 2011, vol. 46, # 7, p. 2930 - 2936
[5] Synthesis (Germany), 2013, vol. 45, # 11, p. 1497 - 1504
[6] Journal of the American Chemical Society, 2016, vol. 138, # 40, p. 13147 - 13150
[7] Chinese Journal of Chemistry, 2018, vol. 36, # 9, p. 815 - 818
  • 26
  • [ 619-45-4 ]
  • [ 318276-74-3 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 18, p. 6395 - 6405
  • 27
  • [ 619-45-4 ]
  • [ 162046-66-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 15, p. 4646 - 4661
  • 28
  • [ 619-45-4 ]
  • [ 219763-85-6 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 6, p. 2232 - 2235
  • 29
  • [ 619-45-4 ]
  • [ 6296-89-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 47, p. 12426 - 12429[2] Angew. Chem., 2013, vol. 125, # 47, p. 12652 - 12656,4
  • 30
  • [ 887144-94-7 ]
  • [ 619-45-4 ]
  • [ 167760-75-0 ]
YieldReaction ConditionsOperation in experiment
67% With tris[2-phenylpyridinato-C2,N]iridium(III) In N,N-dimethyl-formamide at 20℃; Inert atmosphere; Irradiation Under nitrogen or argon, 0.4 mmol, 0.2mmol,Ir (ppy) 3 (2mg) and DMF1 ml was added to the reaction flask, followed by blue LEDlights (7W) at room temperature irradiation straight trivalent iodine reagent completeconversion of the reaction. Add 10 ml of saturated Na 2CO 3Aqueous solution, andextracted three times with ethyl acetate, washed with a saturated brine, dried overanhydrous Na 2SO 4The organic layer was dried. Column chromatography (eluent: petroleum ether 60-90: ethyl acetate = 15: 1-8: 1) to give the product in 67 percent.
Reference: [1] Patent: CN103553857, 2016, B, . Location in patent: Paragraph 0023-0024
[2] Organic Letters, 2014, vol. 16, # 6, p. 1768 - 1771
  • 31
  • [ 619-45-4 ]
  • [ 1024583-33-2 ]
Reference: [1] Patent: US2014/200215, 2014, A1,
  • 32
  • [ 619-45-4 ]
  • [ 664993-53-7 ]
Reference: [1] Patent: WO2013/93508, 2013, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 619-45-4 ]

Aryls

Chemical Structure| 18595-15-8

[ 18595-15-8 ]

Methyl 3-amino-5-methylbenzoate

Similarity: 0.98

Chemical Structure| 18595-12-5

[ 18595-12-5 ]

Methyl 5-amino-2-methylbenzoate

Similarity: 0.98

Chemical Structure| 4518-10-9

[ 4518-10-9 ]

Methyl 3-aminobenzoate

Similarity: 0.98

Chemical Structure| 99-27-4

[ 99-27-4 ]

Dimethyl 5-aminoisophthalate

Similarity: 0.98

Chemical Structure| 6933-47-7

[ 6933-47-7 ]

Methyl 4-amino-2-methylbenzoate

Similarity: 0.98

Esters

Chemical Structure| 18595-15-8

[ 18595-15-8 ]

Methyl 3-amino-5-methylbenzoate

Similarity: 0.98

Chemical Structure| 18595-12-5

[ 18595-12-5 ]

Methyl 5-amino-2-methylbenzoate

Similarity: 0.98

Chemical Structure| 4518-10-9

[ 4518-10-9 ]

Methyl 3-aminobenzoate

Similarity: 0.98

Chemical Structure| 99-27-4

[ 99-27-4 ]

Dimethyl 5-aminoisophthalate

Similarity: 0.98

Chemical Structure| 6933-47-7

[ 6933-47-7 ]

Methyl 4-amino-2-methylbenzoate

Similarity: 0.98

Amines

Chemical Structure| 18595-15-8

[ 18595-15-8 ]

Methyl 3-amino-5-methylbenzoate

Similarity: 0.98

Chemical Structure| 18595-12-5

[ 18595-12-5 ]

Methyl 5-amino-2-methylbenzoate

Similarity: 0.98

Chemical Structure| 4518-10-9

[ 4518-10-9 ]

Methyl 3-aminobenzoate

Similarity: 0.98

Chemical Structure| 99-27-4

[ 99-27-4 ]

Dimethyl 5-aminoisophthalate

Similarity: 0.98

Chemical Structure| 6933-47-7

[ 6933-47-7 ]

Methyl 4-amino-2-methylbenzoate

Similarity: 0.98